Cipla’s Q3FY22 PAT at Rs 729 cr.
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
Avra Labs is a Hyderabad based contract manufacturing and research services (CRAMs) and specialty active pharmaceutical ingredients (API) manufacturer with four facilities across the states of Telangana and Andhra Pradesh
Biocon has reported consolidated financial results for the period ended December 31, 2021
This agreement allows Natco to expand access to Covid-19 medicines in 105 countries in generic name
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
They will commercialize molnupiravir in the international markets
This is the company’s first partnership arrangement in China
The company has 47 ANDA's pending approval with the U.S.FDA
ICICI Direct gives a preview on the earnings narrative for Q3FY22
The stability is led by healthy demand in the domestic and emerging markets
 
        Subscribe To Our Newsletter & Stay Updated